Skip to main content
PMC home page
Gut logoLink to Gut
. 1985 Feb;26(2):133–139. doi: 10.1136/gut.26.2.133

Liver in obesity.

A Braillon, J P Capron, M A Hervé, C Degott, C Quenum
PMCID: PMC1432435  PMID: 3967830

Abstract

We report on clinical, nutritional, and hepatic histological findings in 50 non-selected obese subjects (mean overweight +74%; range +21-138%). The pathogenesis of the liver damage was assessed with the help of multidimensional analysis of a number of clinical variables. According to the severity of the hepatic lesions, the patients have been ranged in five groups: O (normal liver) 10%; I (fatty liver) 48%; II (fatty hepatitis) 26%; III (fatty fibrosis) 8%; IV (fatty cirrhosis) 8%. The more severe changes (groups III and IV) were constantly associated with excessive alcohol intake. The multidimensional analysis was unable to find a relationship between obesity and the development of fibrosis and cirrhosis whereas it showed that: (a) there was a highly significant correlation between the daily ethanol intake and the degree of overweight, (b) severe fatty metamorphosis was significantly associated with the degree of overweight, the existence of diabetes mellitus, and the amount of alcohol and fat intake, (c) nutritional factors, in particular deficient protein intake, have only an accessory effect in the development of mild inflammation and fibrosis, (d) the consumption of potentially hepatotoxic drugs, very high in the obese (about five drugs per day) could have a role in the development of cirrhosis. In conclusion in our study, there was no evidence that obesity per se could result in severe liver damage.

Full text

PDF
133

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adler M., Schaffner F. Fatty liver hepatitis and cirrhosis in obese patients. Am J Med. 1979 Nov;67(5):811–816. doi: 10.1016/0002-9343(79)90740-x. [DOI] [PubMed] [Google Scholar]
  2. Barrison I. G., Viola L., Murray-Lyon I. M. Do housemen take an adequate drinking history? Br Med J. 1980 Oct 18;281(6247):1040–1040. doi: 10.1136/bmj.281.6247.1040. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Capron J. P., Delamarre J., Dupas J. L., Braillon A., Degott C., Quenum C. Fasting in obesity: another cause of liver injury with alcoholic hyaline? Dig Dis Sci. 1982 Mar;27(3):265–268. doi: 10.1007/BF01296926. [DOI] [PubMed] [Google Scholar]
  4. Creutzfeldt W., Frerichs H., Sickinger K. Liver diseases and diabetes mellitus. Prog Liver Dis. 1970;3:371–407. [PubMed] [Google Scholar]
  5. Falchuk K. R., Fiske S. C., Haggitt R. C., Federman M., Trey C. Pericentral hepatic fibrosis and intracellular hyalin in diabetes mellitus. Gastroenterology. 1980 Mar;78(3):535–541. [PubMed] [Google Scholar]
  6. Galambos J. T., Wills C. E. Relationship between 505 paired liver tests and biopsies in 242 obese patients. Gastroenterology. 1978 Jun;74(6):1191–1195. [PubMed] [Google Scholar]
  7. Haines N. W., Baker A. L., Boyer J. L., Glagov S., Schneir H., Jaspan J., Ferguson D. J. Prognostic indicators of hepatic injury following jejunoileal bypass performed for refractory obesity: a prospective study. Hepatology. 1981 Mar-Apr;1(2):161–167. doi: 10.1002/hep.1840010212. [DOI] [PubMed] [Google Scholar]
  8. Hoyumpa A. M., Jr, Greene H. L., Dunn G. D., Schenker S. Fatty liver: biochemical and clinical considerations. Am J Dig Dis. 1975 Dec;20(12):1142–1170. doi: 10.1007/BF01070758. [DOI] [PubMed] [Google Scholar]
  9. Itoh S., Matsuo S., Ichinoe A., Yamaba Y., Miyazawa M. Nonalcoholic steatohepatitis and cirrhosis with Mallory's hyalin with ultrastructural study of one case. Dig Dis Sci. 1982 Apr;27(4):341–346. doi: 10.1007/BF01296754. [DOI] [PubMed] [Google Scholar]
  10. Kern W. H., Heger A. H., Payne J. H., DeWind L. T. Fatty metamorphosis of the liver in morbid obesity. Arch Pathol. 1973 Nov;96(5):342–346. [PubMed] [Google Scholar]
  11. Ludwig J., Viggiano T. R., McGill D. B., Oh B. J. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc. 1980 Jul;55(7):434–438. [PubMed] [Google Scholar]
  12. Marubbio A. T., Rucker R. D., Jr, Schneider P. D., Horstmann J. P., Varco R. L., Buchwald H. The liver in morbid obesity and following bypass surgery for obesity. Surg Clin North Am. 1979 Dec;59(6):1079–1093. doi: 10.1016/s0039-6109(16)41986-9. [DOI] [PubMed] [Google Scholar]
  13. Nasrallah S. M., Wills C. E., Jr, Galambos J. T. Hepatic morphology in obesity. Dig Dis Sci. 1981 Apr;26(4):325–327. doi: 10.1007/BF01308373. [DOI] [PubMed] [Google Scholar]
  14. Powell-Jackson P. R., Maudgal D. P., Sharp D., Goldie A., Maxwell J. D. Intestinal bacterial metabolism of protein and bile acids: role in pathogenesis of hepatic disease after jejuno-ileal bypass surgery. Br J Surg. 1979 Nov;66(11):772–775. doi: 10.1002/bjs.1800661105. [DOI] [PubMed] [Google Scholar]
  15. Sims E. A., Danforth E., Jr, Horton E. S., Bray G. A., Glennon J. A., Salans L. B. Endocrine and metabolic effects of experimental obesity in man. Recent Prog Horm Res. 1973;29:457–496. doi: 10.1016/b978-0-12-571129-6.50016-6. [DOI] [PubMed] [Google Scholar]
  16. Van Waes L., Lieber C. S. Early perivenular sclerosis in alcoholic fatty liver: an index of progressive liver injury. Gastroenterology. 1977 Oct;73(4 Pt 1):646–650. [PubMed] [Google Scholar]
  17. WESTWATER J. O., FAINER D. Liver impairment in the obese. Gastroenterology. 1958 Apr;34(4):686–693. [PubMed] [Google Scholar]
  18. ZELMAN S. The liver in obesity. AMA Arch Intern Med. 1952 Aug;90(2):141–156. doi: 10.1001/archinte.1952.00240080007002. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES